PYA Covid-19 Information Hub
The Role Your Compliance Program Plays in a Transaction: A Cautionary Tale”
Published June 26, 2022

“The Role Your Compliance Program Plays in a Transaction: A Cautionary Tale”

PYA Principal Valerie Rock joined Mary Malone of Hancock Daniel to present at the American Health Law Association’s (AHLA) In-House Counsel Program 2022. Preparing for a transaction with a healthcare entity, whether as the seller or buyer, can be a complex process. It is important to acknowledge the role your compliance program plays in any transaction, from the selling price to the issues that can arise during the due diligence process. In their presentation, “The Role Your Compliance Program Plays in a Transaction: A Cautionary Tale,” Valerie and Mary addressed how to navigate audit activity and corrective actions, and discussed a case study that examined a transaction involving multiple compliance issues. This program provided practical advice that included:

  • Preparation for a transaction from a compliance perspective.
  • Approaches for addressing and resolving identified compliance problems.
  • Advice for entities with good compliance programs, mediocre programs, and non-existent compliance programs.
  • Considerations for the timing of bringing a transaction to market.

The in-person program was held on June 26, 2022, in Chicago.

If you would like additional guidance related to compliance and other matters involving transactions, or any matter related to valuation, compliance, strategy, and transaction services, one of our executive contacts would be happy to assist. You may email them below, or call (800) 270-9629.

Executive Contacts

Interested in Learning More?

Sign Up for Our Insights, Including COVID-19 Bulletins!



    Select Your Subscriptions